Overview
Wound botulism is a rare but serious infectious disease caused by the bacterium Clostridium botulinum, which colonizes a wound and produces botulinum neurotoxin in vivo. Unlike foodborne botulism, the toxin is not ingested but rather produced locally at the site of an infected wound and then absorbed into the bloodstream. The toxin blocks the release of acetylcholine at neuromuscular junctions, leading to progressive descending flaccid paralysis. Wound botulism primarily affects the nervous system and skeletal muscles. It has become increasingly associated with injection drug use, particularly subcutaneous injection ("skin popping") of black tar heroin, as well as traumatic wounds and, rarely, surgical wounds. Key clinical features include cranial nerve palsies (diplopia, blurred vision, ptosis, dysarthria, dysphagia), symmetric descending weakness progressing from the head and neck to the trunk and extremities, and respiratory failure in severe cases. Unlike foodborne botulism, gastrointestinal symptoms such as nausea, vomiting, and diarrhea are typically absent. Patients may also present with a wound that appears infected, though the wound may sometimes appear deceptively benign. Fever may be present due to wound infection but is not caused by the toxin itself. The incubation period is typically 4 to 14 days after wound contamination. Treatment involves prompt administration of equine-derived heptavalent botulinum antitoxin to neutralize circulating toxin and prevent disease progression. Surgical debridement of the infected wound is essential to remove the source of toxin production, along with antibiotic therapy (typically penicillin or metronidazole) directed against Clostridium botulinum. Supportive care, including mechanical ventilation for respiratory failure, is often required. Recovery can take weeks to months as new nerve terminals must regenerate. Early recognition and treatment are critical, as delays in antitoxin administration are associated with worse outcomes and prolonged intensive care stays.
Also known as:
Clinical phenotype terms— hover any for plain English:
Adult
Begins in adulthood (age 18 or older)
Treatments
1 availableIMPAVIDO
treatment of cutaneous leishmaniasis caused by Leishmania guyanensis
Clinical Trials
View all trials with filters →No actively recruiting trials found for Wound botulism at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Wound botulism.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Wound botulism.
Community
No community posts yet. Be the first to share your experience with Wound botulism.
Start the conversation →Latest news about Wound botulism
No recent news articles for Wound botulism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Wound botulism
What is Wound botulism?
Wound botulism is a rare but serious infectious disease caused by the bacterium Clostridium botulinum, which colonizes a wound and produces botulinum neurotoxin in vivo. Unlike foodborne botulism, the toxin is not ingested but rather produced locally at the site of an infected wound and then absorbed into the bloodstream. The toxin blocks the release of acetylcholine at neuromuscular junctions, leading to progressive descending flaccid paralysis. Wound botulism primarily affects the nervous system and skeletal muscles. It has become increasingly associated with injection drug use, particularly
At what age does Wound botulism typically begin?
Typical onset of Wound botulism is adult. Age of onset can vary across affected individuals.